Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) shares increased 4.44% in last trading session and ended the day at $0.94. Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) quarterly performance is -59.48%.
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) announced that it has conferred with Crowe Horwath, HK, the Company’s appointed auditor in relation to the completion of Skystar’s audit for the year ended December 31, 2014 and the review of the Company’s financial statements for the quarters ended March 31, 2015 and June 30, 2015. Based on those communications, Skystar believes that Crowe Horwath is in the process of completing its audit of the Company’s financial statements for the year ended December 31, 2014. However, it is likely that the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2015 and June 30, 2015 will not be completed by the October 12, 2015 deadline provided by NASDAQ to complete those filings (the “Plan of Compliance Deadline”).
Cherokee Inc. (NASDAQ:CHKE) ended the last trading day at $15.79. Company weekly volatility is calculated as 3.43% and price to cash ratio as 14.05. Cherokee Inc. (NASDAQ:CHKE) showed a weekly performance of 1.74%.
On 29 September, Cherokee Global Brands (NASDAQ:CHKE), a global marketer of style-focused lifestyle brands, announced that it has entered into a new license agreement with Saborn Licensing Company BV for its Cherokee(R) brand.
On 07 October, Unifi Inc. (NYSE:UFI) shares increased 0.75% and was closed at $28.30. UFI EPS growth in last 5 year was 33.90%. Unifi Inc. (NYSE:UFI) year to date (YTD) performance is -4.81%.
On 02 October, Unifi Inc. (NYSE:UFI) shares moved down -1.17% and was closed at $28.66. UFI EPS growth in last 5 year was 33.90%. Unifi Inc. (NYSE:UFI) year to date (YTD) performance is -3.60%.
Zacks upgraded shares of Unifi (NYSE:UFI) from a hold rating to a strong-buy rating in a research note published on Friday morning, ARN reports. The firm currently has $34.00 target price on the stock.
ARMOUR Residential REIT (NYSE: ARR) declared a monthly dividend of $0.03 per share, or $0.36 annualized. The dividend will be payable on October 27, 2015, to stockholders of record on October 15, 2015, with an ex-dividend date of October 13, 2015.
ARMOUR Residential REIT, Inc. (NYSE:ARR) shares increased 1.63% in last trading session and ended the day at $21.19. ARR Gross Margin is 25.30% and its has a return on assets of -0.20%. ARMOUR Residential REIT, Inc. (NYSE:ARR) quarterly performance is -6.09%.
Quest Diagnostics Inc. (NYSE:DGX) caters to the Healthcare space. It has a net profit margin of 6.60% and weekly performance is 2.60%. On the last day of trading company shares ended up at $62.68. Quest Diagnostics Inc. (NYSE:DGX) distance from 50-day simple moving average (SMA50) is -7.79%.
Quest Diagnostics (NYSE: DGX), announced that it will provide clinical laboratory testing using the PD-L1 IHC 22C3 PharmDx™ immunohistochemistry companion diagnostic.
Leave a Reply